Quantum Simulation Technologies, Inc., a portfolio company of Abies Ventures, announces the launch of QuantumFP (Quantum FingerPrinting) in QSP Life, which enables automated high-throughput simulation of quantum mechanical fingerprinting of drug-like molecules for data-driven drug discovery.
This new product addresses the growing need for more accurate, reliable, and cost-effective molecular data in modern drug discovery.

In recent years, AI has had a significant impact on the speed of drug discovery activities, and QuantumFP can further accelerate these efforts by improving the predictive accuracy of AI through better molecular characterization.

For more information, please click here.
https://qsimulate.com/news/QuantumFP:_Accelerating_Drug_Discovery_with_Quantum_Fingerprinting